Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.

Anand Govindarajan , Diane Reidy , Martin R. Weiser , Philip B. Paty
Annals of Surgical Oncology 18 ( 13) 3666 -3672

28
2011
Reply to G. Le Flahec et al.

Zsofia K. Stadler , Leonard B. Saltz
Journal of Clinical Oncology 35 ( 3) 378 -378

2017
Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer

John A. Conti , Nancy E. Kemeny , Leonard B. Saltz , A. McKenzie André
Cancer 75 ( 3) 769 -774

19
1995
A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer

Leonard B. Saltz , Cynthia G. Leichman , Charles W. Young , Franco M. Muggia
Cancer 75 ( 3) 782 -785

89
1995
A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma

Eileen M. O'Reilly , Keith E. Stuart , Pedro M. Sanz-Altamira , Gary K. Schwartz
Cancer 91 ( 1) 101 -105

67
2001
Phase II clinical trial of 13‐cis‐retinoic acid and interferon‐α‐2a in patients with advanced esophageal carcinoma

Peter C. Enzinger , David H. Ilson , Leonard B. Saltz , Lisa K. Martin
Cancer 85 ( 6) 1213 -1217

12
1999
Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.

Andrea Cercek , Cara L. Siegel , Marinela Capanu , Diane Reidy-Lagunes
Clinical Colorectal Cancer 12 ( 3) 163 -167

19
2013
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803 / ALLIANCE

Michael Messino , Hedy Kindler , Alan Venook , Charles S. Fuchs
Clinical Colorectal Cancer 12 ( 4) 233 -238

22
2013
Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer

Andrea Cercek , Jinru Shia , Marc Gollub , Joanne F. Chou
Clinical Colorectal Cancer 13 ( 4) 207 -212

30
2014
Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer.

Shu Y. Ng , Kathryn L. Colborn , Lajhem Cambridge , Andrea Cercek
Clinical Colorectal Cancer 18 ( 3) 167 -174

2019
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

Leonard B. Saltz , John V. Cox , Charles Blanke , Lee S. Rosen
New England Journal of Medicine 343 ( 13) 905 -914

3,789
2000
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.

Tina Dasgupta , Diana Rothenstein , Joanne F. Chou , Zhigang Zhang
Radiotherapy and Oncology 107 ( 2) 189 -194

33
2013
Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer

Alfred T Culliford , Ari D. Brooks , Sunil Sharma , Leonard B. Saltz
Annals of Surgical Oncology 8 ( 10) 787 -795

115
2001
Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment.

Howard A. Burris , Leonard B. Saltz , Peter P. Yu
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 38 ( 38) 139 -146

4
2018
PD-1 Blockade in Advanced Adrenocortical Carcinoma

Nitya Raj , Youyun Zheng , Virginia Kelly , Seth S. Katz
Journal of Clinical Oncology 38 ( 1) 71 -80

35
2020
Value-Added Decisions in Oncology.

Ian Tannock , Carolyn J. Presley , Leonard B. Saltz
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 39 ( 39) 122 -131

3
2019
Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade?

Alan P. Venook , Leonard B. Saltz
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 33 ( 33) 121 -125

2
2013